Although miR-122-5p and CDC25A have been studied in several malignancies such as hepatocellular carcinoma and acute myeloid leukemia, their coordinated regulatory relationship within the molecular context of BCR::ABL1-positive chronic myeloid leukemia has not been previously characterized. This evidence concerns the gene CDC25A and acute myeloid leukemia.